Epizyme
Utility Patent Applications
Last updated:
List of all Epizyme patents 92 in total
| Status | Patent |
|---|---|
Application | Utility: ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: METHOD OF TREATING MEDULLOBLASTOMA WITH AN EZH2 INHIBITOR Filling date: 7 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: METHODS OF TREATING CANCER Filling date: 7 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS, SALTS THEREOF, AND METHODS OF SYNTHESIS THEREOF Filling date: 7 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: USE OF EZH2 INHIBITORS FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 28 May 2020 |
Application | Utility: ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: METHOD FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: ISOXAZOLE CARBOXAMIDE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: METHOD OF TREATING MALIGNANT RHABDOID TUMOR OF THE OVARY (MRTO)/SMALL CELL CANCER OF THE OVARY OF THE HYPERCALCEMIC TYPE(SCCOHT) WITH AN EZH2 INHIBITOR Filling date: 7 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: Substituted Cyclohexylamine Compounds Filling date: 7 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: DOT1L INHIBITORS FOR USE IN THE TREATMENT OF LEUKEMIA Filling date: 7 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: METHODS OF USING EHMT2 INHIBITORS Filling date: 7 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: SUBSTITUTED PYRROLIDINE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: INHIBITION OF SMARCA2 FOR TREATMENT OF CANCER Filling date: 7 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: COMBINATION THERAPIES WITH EHMT2 INHIBITORS Filling date: 7 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: SUBSTITUTED PYRROLIDINE CARBOXAMIDE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS AND METHODS OF USE THEREOF Filling date: 7 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: SUBSTITUTED FUSED BI- OR TRI- HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS Filling date: 7 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: PRMT5 INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: EZH2 INHIBITORS FOR TREATING LYMPHOMA Filling date: 7 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF Filling date: 7 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: METHOD FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: TREATMENT OF LEUKEMIA VIA THE ADMINISTRATION OF DOT1L INHIBITOR PINOMETOSTAT Filling date: 7 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: INJECTABLE FORMULATIONS FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: INJECTABLE FORMULATIONS FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: CANCER TREATMENT MODALITIES Filling date: 7 Sep 2025 Issue date: 21 Nov 2019 |
Application | Utility: TETRAHYDRO- AND DIHYDRO-ISOQUINOLINE PRMT5 INHIBITORS AND USES THEREOF Filling date: 7 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: EZH2 INHIBITORS FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: SMYD INHIBITORS Filling date: 7 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: COMBINATION THERAPY FOR TREATING CANCER Filling date: 7 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS Filling date: 7 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS Filling date: 7 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR Filling date: 7 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: CREBBP RELATED CANCER THERAPY Filling date: 7 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: EZH2 INHIBITORS FOR TREATING LYMPHOMA Filling date: 7 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: Isoxazole Carboxamides as Irreversible SMYD Inhibitors Filling date: 7 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: METHOD OF TREATING CANCER Filling date: 7 Sep 2025 Issue date: 8 Aug 2019 |
Showing 50 to 92 of 92 patents.